ETR:CCAP CORESTATE Capital (CCAP) Stock Price, News & Analysis €0.28 +0.00 (+1.48%) As of 07/4/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About CORESTATE Capital Stock (ETR:CCAP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CORESTATE Capital alerts:Sign Up Key Stats Today's Range€0.27▼€0.2950-Day Range€0.24▼€0.2952-Week Range€0.26▼€0.76Volume19,772 shsAverage VolumeN/AMarket Capitalization€45.60 millionP/E RatioN/ADividend Yield909.09%Price TargetN/AConsensus RatingN/A Company Overview CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC. Read More Receive CCAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address CCAP Stock News HeadlinesCorestate Capital Holding S.A.May 27, 2025 | barrons.comEQS-Adhoc: Corestate Capital Holding S.A.: Corestate to sell STAM Europe SASApril 10, 2025 | markets.businessinsider.comBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.July 5 at 2:00 AM | Crypto 101 Media (Ad)Corestate Capital Holding SANovember 9, 2024 | morningstar.comMWells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)October 29, 2024 | markets.businessinsider.comLadenburg Thalmann Initiates Coverage of Crescent Capital BDC (CCAP) with Buy RecommendationOctober 1, 2024 | msn.comCrescent Capital: It Has Become A Better Buy After Q1 2024May 29, 2024 | seekingalpha.comCrescent Capital BDC, Inc. (NASDAQ:CCAP) Q1 2024 Earnings Call TranscriptMay 10, 2024 | msn.comSee More Headlines CCAP Stock Analysis - Frequently Asked Questions How have CCAP shares performed this year? CORESTATE Capital's stock was trading at €0.36 at the beginning of the year. Since then, CCAP shares have decreased by 23.6% and is now trading at €0.28. What other stocks do shareholders of CORESTATE Capital own? Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), ARAVIVE (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA). Industry, Sector and Symbol Stock ExchangeETR SectorReal Estate Industry Real Estate Services Sub-IndustryFinancial Services Current SymbolETR:CCAP CIKN/A Webwww.corestate-capital.ch Phone352 26 6372 20FaxN/AEmployees446Year FoundedN/AProfitability EPS (Trailing Twelve Months)(€21.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.01Net Income-€3.50 billion Net Margins-1,143.36% Pretax MarginN/A Return on Equity-269.30% Return on Assets-7.35% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick Ratio0.17 Sales & Book Value Annual Sales€306.04 million Price / Sales0.15 Cash Flow€0.46 per share Price / Cash Flow0.60 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares165,831,023Free FloatN/AMarket Cap€45.60 million OptionableNot Optionable Beta1.03 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (ETR:CCAP) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CORESTATE Capital Holding S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share CORESTATE Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
